-
- Paul Young, Carol Hodgson, Joel Dulhunty, Manoj Saxena, Michael Bailey, Rinaldo Bellomo, Andrew Davies, Simon Finfer, Peter Kruger, Jeffrey Lipman, John Myburgh, Sandra Peake, Ian Seppelt, Stephen Streat, Rhiannon Tate, Steven Webb, and ANZICS Clinical Trials Group.
- Wellington Regional Hospital, Capital and Coast District Health Board, Wellington, New Zealand.
- Crit Care Resusc. 2012 Sep 1;14(3):211-5.
BackgroundThere is uncertainty about which end points should be used for Phase II trials in critically ill patients.ObjectiveTo systematically evaluate potential end points for Phase II trials in critically ill patients.Design And SettingA report outlining a process of literature review and recommendations from a consensus meeting conducted on behalf of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG) in October 2011.Results And ConclusionsThe consensus panel concluded that there are no adequately validated end points for Phase II trials in critically ill patients. However, the following were identified as potential Phase II end points: hospital-free days to Day 90, ICU-free days to Day 28, ventilator-free days to Day 28, cardiovascular support-free days to Day 28, and renal replacement therapy-free days to Day 28. We recommend that these end points be evaluated further.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..